Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation Biotech Investing
Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy Opportunity on September 29, 2025 Biotech Investing
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes Biotech Investing
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting Biotech Investing
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
